In today’s recent session, 0.76 million shares of the Neurogene Inc (NASDAQ:NGNE) have been traded, and its beta is 1.35. Most recently the company’s share price was $20.65, and it changed around -$13.86 or -40.17% from the last close, which brings the market valuation of the company to $236.24M. NGNE at last check was trading at a discount to its 52-week high of $74.49, offering almost -260.73% off that amount. The share price’s 52-week low was $12.49, which indicates that the recent value has risen by an impressive 39.52% since then. We note from Neurogene Inc’s average daily trading volume that its 10-day average is 0.61 million shares, with the 3-month average coming to 184.75K.
Neurogene Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.14. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended NGNE as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Neurogene Inc is expected to report earnings per share of -1.22 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Neurogene Inc (NASDAQ:NGNE) trade information
Instantly NGNE has been showing red trend so far today with a performance of -40.17% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 49.37 on recent trading dayincreased the stock’s daily price by 58.17%. The company’s shares are currently up 6.55% year-to-date, but still down -71.13% over the last five days. On the other hand, Neurogene Inc (NASDAQ:NGNE) is -62.04% down in the 30-day period. We can see from the shorts that 0.91 million shares have been sold at a short interest cover period of 7.15 day(s).
The consensus price target as assigned by Wall Street analysts is $57, which translates to bulls needing to increase their stock price by 63.77% from its current value. Analyst projections state that NGNE is forecast to be at a low of $49 and a high of $60.
Neurogene Inc (NGNE) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -16.09%. Neurogene Inc earnings are expected to increase by -250.99% in 2024, but the outlook is positive 25.10% per year for the next five years.
